The Swiss Medtech Award 2025 goes to Qumea
The Solothurn-based digital health company Qumea wins the Swiss Medtech Award 2025. The scale-up beat two other finalists and impressed the jury with its innovative solution for contactless, radar-based motion analysis in care rooms.
The Swiss Medtech Award is presented annually by the industry association Swiss Medtech and is endowed with CHF 50,000. It recognizes projects that combine medical innovation, marketability and benefits for the healthcare system. The association represents the interests of over 700 medtech companies in Switzerland and is committed to their international competitiveness and optimal framework conditions.
At the forefront of digitalization
For the Solothurn-based scale-up Qumea, winning the award is a great recognition. CEO and co-founder of the company Cyrill Gyger emphasizes that he is delighted to have won the highly endowed prize. The award shows that digital change has also arrived in the traditional medtech sector and that the industry is working intensively with new technologies. "It makes us proud to be at the forefront of actively shaping the digital transformation in the medtech industry with Qumea and providing impetus for the future," says Gyger.
CTO Jonas Reber also underlines the signal effect of the jury's decision: "Artificial intelligence and medtech are growing ever closer together - just as precision mechanics or miniaturization have driven innovation in the past. I am delighted that we can contribute to this change with Qumea."
Radar detects movements and alerts if there is a risk of falling
Qumea has developed a solution for digital mobility monitoring in care rooms. The system records anonymous radar-based movement data, evaluates it, visualizes it and automatically provides information about dangerous situations. Patient privacy is protected as no cameras or microphones are used. In acute care, an average reduction in falls of 74 % was achieved. According to Qumea, this sets a new standard in proactive and preventative patient care.
The award was presented on June 25, 2025 as part of the Swiss Medtech Day 2025 in Bern - the leading platform for the Swiss medical technology sector, where experts from industry, research and healthcare network every year. In addition to Qumea, evismo, with a solution for diagnosing heart, sleep and stress disorders, and Bonebridge, a provider of innovative implants for the treatment of bone fractures, were also nominated for the award.
Source and further information: Qumea
